|
Mr. Skaletsky has been a director of Alkermes since June 2004. He is currently Chairman, CEO and President of Trine Pharmaceuticals, Inc. Previously, Mr. Skaletsky was President and CEO of GelTex Pharmaceuticals, Inc. which was acquired by Genzyme in December 2000. Mr. Skaletsky held the position of Chairman and CEO of Enzytech, Inc., from 1988 to 1993, and he was President and Chief Operating Officer of Biogen, Inc., from 1981 to 1988. Mr. Skaletsky was among the founders of the Industrial Biotechnology Association, a predecessor to the Biotechnology Industry Organization (BIO), and is a former chairman of BIO. He serves on the Board of Directors of ImmunoGen, Inc., Dormantis, Inc., Advanced Magnetics, Inc, Targacept, Inc., and Icoria, Inc. In addition, Mr. Skaletsky is a member of the Board of Trustees of Bentley College. | 